| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhat are the selected lasting-eyesight/eye-health question and verdict?Required |
The selected wording is “Lasting improvement in eyesight or eye health,” with original grade ? and note “Duration and clinical function were not measured.” Absent subclaim score, status and axes are distinguished from parent acute C54. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Existing claim of lasting improvement in eyesight or eye health |
Material needed: Direct persistence, everyday clinical-function and eye-health material, and applicability review, remain needed. ? is not converted into effect 0, score 0 or absence of all research. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWas duration of effect directly measured?Required |
There was one test about 1.75 hours after a single serving; the subclaim note and parent summary record that duration was not measured. Testing within 2 hours is not a guarantee of persistence for 2 hours or long-term follow-up. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Acute test timing versus persistence follow-up |
Material needed: Later time-specific tests, effects/CIs, exposure, denominators, post-treatment follow-up and duration definitions are needed. No new duration or effect is inferred. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWas everyday clinical function directly tested?Required |
The subclaim note records unmeasured clinical function; the historical counterview records untested everyday function/repeated-ingestion effects. Small-letter test signals are not converted into direct effects on everyday activities or restored eyesight. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Laboratory psychophysical tests versus clinical function |
Material needed: Definitions, measurements, denominators, comparators and effects/CIs for patient-important function, everyday activities and long-term eyesight are needed. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat are the original acute small-letter contrast values?Required |
In the 30-person crossover trial, small-letter logCS was dark 1.45 versus milk 1.30, with mean difference 0.15, 95% CI 0.08 to 0.22, P<.001. Existing differences/intervals are preserved without transfer to lasting eyesight effects. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original logCS effects/CIs and direct measurement timing |
Material needed: Separate originals for persistence/clinical questions and acute tables, definitions, models and condition-specific denominators are needed. No new effects, CIs or relative changes are calculated. This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionDoes large-letter contrast show the same result?Required |
The original research description records a large-letter difference of 0.05 logCS, P=.07. The small-letter 0.15 CI/P value is not copied as large-letter success or persistence, and the large-letter CI gap remains. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Distinguishing small- and large-letter logCS |
Material needed: Large-letter tests, denominators, effects/CIs, prior hierarchy, multiplicity and direct persistence material are needed. P=.07 does not certify effect 0 or equivalence. This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionAre visual acuity in logMAR and contrast in logCS the same?Required |
The original acuity difference of 0.04 logMAR, P=.05, is borderline and differs from contrast in logCS. Small-letter signals are not converted into successful eyesight restoration or other units. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Distinguishing acuity/contrast measures and units |
Material needed: Original acuity tables, condition-specific denominators, comparative CIs, exact times, prior hierarchy, importance and persistence material are needed. This records needed materials; no new research was executed. |
| 7 |
Unverified |
Full text not readStored summary read |
N07 · Evidence conditionAre clinical eye-health or eye-disease event data available?Required |
The preserved report is a single-exposure acuity/contrast experiment. Eye-health event types/counts, disease progression/recovery, follow-up and time at risk are not established as direct results in the current stored summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Specific eye-health endpoints and clinical-event gaps |
Material needed: Disease/event definitions, clinical adjudication, group-specific events/denominators, follow-up and original CIs are needed. Unverified data are not converted into event 0 or preventive effect 0. This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionAre healthy young adults the same as eye-disease patients?Required |
The original population is 30 healthy young adults without eye disease. The same effect is not generalized to disease treatment, restored eyesight, other ages or risk groups; exact age and baseline test details are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
30 people without eye disease, eligibility and generalization |
Material needed: Eligibility, exclusions, age, baseline vision, eye disease, medicines and original denominators for direct long-term populations are needed. This records needed materials; no new research was executed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionIs the actual comparison dark versus milk chocolate?Required |
These are two single-exposure conditions using tested dark and milk chocolate. Milk is not replaced by no ingestion/placebo, and the same effect of general high-cacao products is not established. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Two tested foods and an active control |
Material needed: Product composition, actual exposure, flavanols, cacao, sugar, calories, control matching and masking material are needed. No amounts or product recommendations are created. This records needed materials; no new research was executed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionDoes cacao percentage alone ensure the same flavanol exposure?Required |
Existing product information states that general-product cacao percentage alone cannot guarantee the tested flavanol dose. Product amounts or active content absent from the stored summary are not filled by calculation or inference. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Tested versus general products and unrecorded amounts |
Material needed: Tested-product quantities, ingredients, batch, manufacturing, actual exposure and control composition are needed. No new ingestion doses or long-term exposure examples are created. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAre the 30 crossover participants new people in each condition?Required |
The original report concerns a 30-person within-person crossover with one session per condition. Two conditions/multiple visual tests in the same people are not added as new participants. Valid outcome denominators, session exclusions and order/period effects are separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Within-person single-exposure conditions, denominators and repeats |
Material needed: Allocation order, periods, washout, carryover, condition/outcome denominators, missingness and within-person models are needed. No new total observations or participant counts are calculated. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionAre single masking and possible chocolate recognition distinguished?Required |
The original design is a single-masked crossover; the historical counterview says participants could recognize chocolate types. Actual recognition rates and masking tests are not established in the stored summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Measurement/participant masking and bias |
Material needed: Who was masked, concealment, recognition assessment, assessors, test learning, order and missing-data originals are needed. Possibility is not regraded as a confirmed violation or null effect. This records needed materials; no new research was executed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionDid registration and prior outcomes include the lasting-effect question?Required |
Original NCT03326934 and the bibliography for acute acuity/large-letter/small-letter tests are preserved. Registry contents/dates, exact prior hierarchy and long-term eye-health endpoints were not read this time; no new prespecification certification is made. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
NCT03326934 and acute/long-term hierarchy |
Material needed: Initial registration, change history, protocols, SAPs, outcomes/times, multiplicity and analysis populations are needed. Identifiers are distinguished from actual content verification. This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionDoes the acute CI establish precision of lasting effects?Required |
The acute small-letter CI 0.08 to 0.22 is preserved; the parent records clear exclusion of 0. It does not provide effects/CIs for lasting eyesight or clinical events. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Acute CI versus precision of persistence/clinical effects |
Material needed: Direct long-term effects/CIs, patient importance, denominators and follow-up are needed. Parent C0/effect-size interpretation is not transferred to long-term subclaim values. This records needed materials; no new research was executed. |
| 15 |
Unverified |
Full text not readStored summary read |
N15 · Evidence conditionAre data available on repeated ingestion and post-treatment persistence?Required |
The preserved scope is a single-exposure acute signal with duration/clinical function unmeasured. Benefits of repeated ingestion or long-term eye health are not established as success of the same trial. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Repeated exposure and direct long-term function/events |
Material needed: Repeated/later function, disease endpoints, denominators, CIs, actual exposure and harms with the same product/control are needed. Only research needs are recorded; no ingestion, product or treatment instructions are created. This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionAre the same trial, eyes and conditions counted as new independent material?Required |
Parent 2988 and the two existing subclaims share the same original report context. Sheets, visual tests, conditions, eyes and repeated measurements are not counted as new independent trials/participants; unique-trial/participant totals are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Shared bibliography/participants across parent and two subclaims |
Material needed: Links among reports, populations, people, eyes, times, conditions and analysis populations are needed. Material slots are not quality scores or unique-trial counts. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionWhat material was actually read?Required |
The complete parent stored summary was read for production and preserved in full. External abstracts, full text, registration, protocols and SAPs remain unread; URL/PMCID existence is not promoted to actual reading/access/condition fulfillment. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Complete parent stored summary versus external reading |
Material needed: Actual original papers, appendices, registration, plans and reading records are needed. External-source content verification and link testing were not performed this time. This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat are the bibliographic and registration identifiers?Required |
Original PMID 29710322, PMCID PMC6145773, DOI 10.1001/jamaophthalmol.2018.0978 and the PubMed URL are preserved. NCT03326934 is recorded in the evidence/citation lists; contents, dates and prespecification were not read this time. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
PMID, PMCID, DOI and registration identification/content |
Material needed: Accurate paper/full-text/registration links, contents and dates are needed. New full-text/registration URLs are not inferred from identifiers. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionAre original bilingual text and historical checks distinguished from current review?Required |
Original Korean/English text, subclaim/note and historical original-paper, bibliographic, effect-size and scoring-check statements are preserved. This separation work is not a new clinical review, calculation or verdict. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original Korean/English text, subclaim wording and historical scope |
Material needed: Content review of originals, detailed translation, corrections and question boundaries remains incomplete. Historical checks are not labeled independent clinical verification now. This records needed materials; no new research was executed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionAre subclaim values distinguished from parent C54, axes and safety?Required |
Subclaim ?/note and absent score/status/axes are retained. Parent C54, Good safety, B/S/R1/I2/E+/B2/C0, four false flags and empty override reasons concern the acute context and do not fill long-term subclaim scores, safety or independence. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Subclaim grade/note and absent score/status/axes |
Material needed: Content review of selected/parent original values remains incomplete. No new efficacy grades, scores, axes or regrading are created. This records needed materials; no new research was executed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionAre the evidence date and corrections distinguished from production dates?Required |
Original 2026-09-07, the empty corrections array and empty deliberation string are retained. They are not production/review dates or certification of no external corrections. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original evidence date and empty correction/deliberation records |
Material needed: Later/correction originals, complete before-change text and event history are needed. Absent dates/correction values are not arbitrarily filled. This records needed materials; no new research was executed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre funding, product support, employee authors and analysis roles distinguished?Required |
The original funding record describes a university research team with no commercial manufacturer involvement identified in the report. This differs from support, affiliation and analysis-role details; product support, employee authors and analytic involvement are not automatically filled as absent. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Four company-related dimensions and original independence statements |
Material needed: Original funding/competing interests, product support, author affiliations and analysis/publication roles are needed. Parent I2 is not promoted to new independence certification. This records needed materials; no new research was executed. |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Evidence conditionAre allocation, measurement, missingness and selective-reporting details available?Required |
Single-masked within-person crossover, other visual measures and possible participant recognition of foods are retained. Allocation/order, measurement/test learning, missingness and selective-reporting details are separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original design, hierarchy and denominators |
Material needed: Methods, protocols, SAPs, registry changes, original tables, effects of interest and denominators are needed. Design labels alone do not certify official RoB/GRADE or passed content review. This records needed materials; no new research was executed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionHave actual exposure, concurrent care and repetition been verified?Required |
Single exposure to particular dark/milk chocolate and testing about 1.75 hours later are preserved as research-identification information. Product amounts, active ingredients, concurrent meals/other ingestion and actual-exposure details are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original intervention identity, adherence and co-interventions |
Material needed: Product/formulation quantities, actual exposure, concurrent care, intervention deviations and denominators are needed. No total amounts or ingestion/product/eye-health instructions are created. This records needed materials; no new research was executed. |
| 25 |
Unverified |
Full text not readStored summary read |
N25 · Evidence conditionAre harm-reporting scope and actual denominators distinguished?Supplementary |
The original single food exposure was not a systematic safety trial; it records product/person boundaries for allergy, caffeine sensitivity, sugar and calories. Harm counts/rates, active collection and denominators are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original safety statements, collection and exposure denominators |
Material needed: Harm definitions, collection, actual exposure/denominators, discontinuation, dropout, severity and control originals are needed. Original Good safety is not transferred to safety in all populations/durations. This records needed materials; no new research was executed. |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Evidence conditionWhat are the boundaries for long-term/rare harms and other populations?Supplementary |
Single-exposure results in healthy adults do not certify safety of long-term/repeated ingestion or all products/disease populations. Original boundaries for allergy, caffeine and calories are retained. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original duration, illnesses, medicines and long-term boundaries |
Material needed: Long-term exposure/follow-up, harm surveillance, risk groups, medicines, denominators, CIs and event data are needed. No new treatment, ingestion or care instructions are provided. This records needed materials; no new research was executed. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionWhat material would trigger a sheet update?Required |
This table transfers stored material about lasting eyesight/eye health. Content-review results for original tables, measures, times, people, eyes, denominators, comparators, concurrent care, follow-up, support and harms can be linked to separate update events. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Conditions, observations, original material and verdict-change events |
Material needed: Complete before-change copies, original material, condition versions, separate application and content-review records are needed. Material additions, condition revisions and verdict changes are distinguished. This records needed materials; no new research was executed. |